49661-2
HIV protease gene mutations by Phenotype method
Active
30296-8 Amprenavir [Susceptibility] by Phenotype method
Part Descriptions
LP21307-1 Amprenavir
Amprenavir (Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. Production of amprenavir was discontinued by the manufacturer December 31, 2004; a prodrug version (fosamprenavir) is available.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Amprenavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Amprenavir Islt Phenotyp
- Display Name
- Amprenavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amprenavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41252-4 | AmprenavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | amprenavir: |
| es-ES | Spanish (Spain) | Amprenavir: |
| es-MX | Spanish (Mexico) | Amprenavir: |
| et-EE | Estonian (Estonia) | Amprenaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Amprénavir: |
| fr-FR | French (France) | Amprénavir: |
| fr-BE | French (Belgium) | Amprénavir: |
| it-IT | Italian (Italy) | Amprenavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | Amprenavir: |
| nl-NL | Dutch (Netherlands) | amprenavir: |
| pt-BR | Portuguese (Brazil) | Amprenavir: Synonyms: Amp; |
| tr-TR | Turkish (Turkey) | Amprenavir: |
| zh-CN | Chinese (China) | 安普那韦: Synonyms: 分离物; |
49668-7 Atazanavir [Susceptibility] by Phenotype method
Part Descriptions
LP35785-2 Atazanavir
Atazanavir is an antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP35785-2 Atazanavir
Atazanavir, marketed under the trade name Reyataz is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Atazanavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Atazanavir Islt Phenotyp
- Display Name
- Atazanavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Atazanavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 17375
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41265-6 | AtazanavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Atazanavir: |
| es-ES | Spanish (Spain) | Atazanavir: |
| es-MX | Spanish (Mexico) | Atazanavir: |
| et-EE | Estonian (Estonia) | Atatsanaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Atazanavir: |
| fr-FR | French (France) | Atazanavir: |
| fr-BE | French (Belgium) | Atazanavir: |
| it-IT | Italian (Italy) | Atazanavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | atazanavir: |
| pt-BR | Portuguese (Brazil) | Atazanavir: Synonyms: ATV; |
| tr-TR | Turkish (Turkey) | Atazanavir: |
| zh-CN | Chinese (China) | 阿他那韦: Synonyms: 分离物; |
49666-1 Darunavir [Susceptibility] by Phenotype method
Part Descriptions
LP64724-5 Darunavir
Darunavir (Prezista) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois in Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Darunavir
LP64724-5 Darunavir
Darunavir (brand name Prezista, formerly known as TMC114) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Darunavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Darunavir Islt Phenotyp
- Display Name
- Darunavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Darunavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.22
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41328-2 | DarunavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Darunavir: |
| es-MX | Spanish (Mexico) | Darunavir: |
| et-EE | Estonian (Estonia) | Darunaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Darunavir: |
| fr-FR | French (France) | Darunavir: |
| fr-BE | French (Belgium) | Darunavir: |
| it-IT | Italian (Italy) | Darunavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | darunavir: |
| pt-BR | Portuguese (Brazil) | Darunavir: Synonyms: Prezista; |
| tr-TR | Turkish (Turkey) | Darunavir: |
| zh-CN | Chinese (China) | 地瑞那韦: Synonyms: Darunavir; |
42500-9 Fosamprenavir [Susceptibility] by Phenotype method
Part Descriptions
LP36119-3 Fosamprenavir
Viral genomic sequencing is performed on patient plasma. Genomic mutations may occur, resulting in resistance to specific antiretroviral drugs. Fosamprenavir is an antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP36119-3 Fosamprenavir
Fosamprenavir is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Fosamprenavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Fosamprenavir Islt Phenotyp
- Display Name
- Fosamprenavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Fosamprenavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16896
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41300-1 | FosamprenavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Fosamprenavir: |
| es-MX | Spanish (Mexico) | Fosamprenavir: |
| et-EE | Estonian (Estonia) | Fosamprenaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Fosamprénavir: |
| fr-FR | French (France) | Fosamprénavir: |
| fr-BE | French (Belgium) | Fosamprénavir: |
| it-IT | Italian (Italy) | Fosamprenavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 포삼프레나비어: |
| nl-NL | Dutch (Netherlands) | fosamprenavir: |
| pt-BR | Portuguese (Brazil) | Fosamprenavir: Synonyms: FPV; |
| tr-TR | Turkish (Turkey) | Fosamprenavir: |
| zh-CN | Chinese (China) | 夫沙那韦: Synonyms: HIV 蛋白酶抑制剂; |
30278-6 Indinavir [Susceptibility] by Phenotype method
Part Descriptions
LP21311-3 Indinavir
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
Source: National Library of Medicine, MeSH 2006
LP21311-3 Indinavir
Indinavir (IDV) is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Indinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Indinavir Islt Phenotyp
- Display Name
- Indinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Indinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17814
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41248-2 | IndinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | indinavir: |
| es-ES | Spanish (Spain) | Indinavir: |
| es-MX | Spanish (Mexico) | Indinavir: |
| et-EE | Estonian (Estonia) | Indinaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Indinavir: |
| fr-FR | French (France) | Indinavir: |
| fr-BE | French (Belgium) | Indinavir: |
| it-IT | Italian (Italy) | Indinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | Indinavir: |
| nl-NL | Dutch (Netherlands) | indinavir: |
| pt-BR | Portuguese (Brazil) | Indinavir: Synonyms: Crixivan; |
| tr-TR | Turkish (Turkey) | Indinavir: |
| zh-CN | Chinese (China) | 茚地那韦: Synonyms: IDV; |
34643-7 Lopinavir [Susceptibility] by Phenotype method
Part Descriptions
LP28756-2 Lopinavir
Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is marketed by Abbott as Kaletra (high-income countries) and Aluvia (low-income countries), both of which represent a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
LP28756-2 Lopinavir
Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used as a fixed-dose combination with another protease inhibitor, ritonavir, under the trade names Kaletra and Aluvia.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Lopinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Lopinavir Islt Phenotyp
- Display Name
- Lopinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Lopinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.11
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16253
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41217-7 | LopinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | lopinavir: |
| es-ES | Spanish (Spain) | Lopinavir: |
| es-MX | Spanish (Mexico) | Lopinavir: |
| et-EE | Estonian (Estonia) | Lopinaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Lopinavir: |
| fr-FR | French (France) | Lopinavir: |
| fr-BE | French (Belgium) | Lopinavir: |
| it-IT | Italian (Italy) | Lopinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 로피나비르: |
| nl-NL | Dutch (Netherlands) | lopinavir: |
| pt-BR | Portuguese (Brazil) | Lopinavir: Synonyms: Kaletra; |
| tr-TR | Turkish (Turkey) | Lopinavir: |
| zh-CN | Chinese (China) | 洛匹那韦: Synonyms: LPV 分离物; |
30280-2 Nelfinavir [Susceptibility] by Phenotype method
Part Descriptions
LP21313-9 Nelfinavir
Nelfinavir (Viracept ®) is an antiretroviral drug used in the treatment of the human immunodeficiency virus (HIV). Nelfinavir belongs to the class of drugs known as protease inhibitors (PIs) and like other PIs is generally used in combination with other antiretroviral drugs. Nelfinavir is presented as the mesilate (mesylate) ester prodrug.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Nelfinavir (Wikipedia)
LP21313-9 Nelfinavir
Nelfinavir is a Protease Inhibitor (PI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Nelfinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Nelfinavir Islt Phenotyp
- Display Name
- Nelfinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Nelfinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19592
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41250-8 | NelfinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | nelfinavir: |
| es-ES | Spanish (Spain) | Nelfinavir: |
| es-MX | Spanish (Mexico) | Nelfinavir: |
| et-EE | Estonian (Estonia) | Nelfinaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Nelfinavir: |
| fr-FR | French (France) | Nelfinavir: |
| fr-BE | French (Belgium) | Nelfinavir: |
| it-IT | Italian (Italy) | Nelfinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | Nelfinavir: |
| nl-NL | Dutch (Netherlands) | Nelfinavir: |
| pt-BR | Portuguese (Brazil) | Nelfinavir: Synonyms: Viracept; |
| tr-TR | Turkish (Turkey) | Nelfinavir: |
| zh-CN | Chinese (China) | 奈非那韦: Synonyms: NFV 分离物; |
30279-4 Ritonavir [Susceptibility] by Phenotype method
Part Descriptions
LP21314-7 Ritonavir
Ritonavir, with trade name Norvir® (Abbott Laboratories), is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS. Ritonavir is frequently prescribed as the protease inhibitor component in HAART because it inhibits the same host enzyme that metabolizes NRTIs and NNRTIs. This inhibition leads to higher plasma concentrations of these latter drugs, allowing the clinician to lower their dose and frequency.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ritonavir (Wikipedia)
LP21314-7 Ritonavir
Viral genomic sequencing is performed on patient plasma. Genomic mutations may occur, resulting in resistance to specific antiretroviral drugs. Ritonavir is a Protease Inhibitor (PI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Ritonavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Ritonavir Islt Phenotyp
- Display Name
- Ritonavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ritonavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41249-0 | RitonavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ritonavir: |
| es-AR | Spanish (Argentina) | ritonavir: |
| es-ES | Spanish (Spain) | Ritonavir: |
| es-MX | Spanish (Mexico) | Ritonavir: |
| et-EE | Estonian (Estonia) | Ritonaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Ritonavir: |
| fr-FR | French (France) | Ritonavir: |
| fr-BE | French (Belgium) | Ritonavir: |
| it-IT | Italian (Italy) | Ritonavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 리토나비어: |
| nl-NL | Dutch (Netherlands) | ritonavir: |
| pt-BR | Portuguese (Brazil) | Ritonavir: Synonyms: Norvir; |
| tr-TR | Turkish (Turkey) | Ritonavir: |
| zh-CN | Chinese (China) | 利托那韦: Synonyms: RTV; |
30281-0 Saquinavir [Susceptibility] by Phenotype method
Part Descriptions
LP14466-4 Saquinavir
Saquinavir is a Protease Inhibitor (PI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP14466-4 Saquinavir
Saquinavir is an antiretroviral drug used in HIV therapy. It falls in the protease inhibitor class.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Saquinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Saquinavir Islt Phenotyp
- Display Name
- Saquinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Saquinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41251-6 | SaquinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | saquinavir: |
| es-ES | Spanish (Spain) | Saquinavir: |
| es-MX | Spanish (Mexico) | Saquinavir: |
| fr-CA | French (Canada) | Saquinavir: |
| fr-FR | French (France) | Saquinavir: |
| fr-BE | French (Belgium) | Saquinavir: |
| it-IT | Italian (Italy) | Saquinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 사퀴나비르: |
| nl-NL | Dutch (Netherlands) | saquinavir: |
| pt-BR | Portuguese (Brazil) | Saquinavir: Synonyms: Fortovase; |
| tr-TR | Turkish (Turkey) | Sakuinavir: |
| zh-CN | Chinese (China) | 沙奎那韦: Synonyms: SQV 分离物; |
49667-9 Tipranavir [Susceptibility] by Phenotype method
Part Descriptions
LP36120-1 Tipranavir
anti-viral drug
Source: Regenstrief Institute
LP36120-1 Tipranavir
Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Tipranavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Tipranavir Islt Phenotyp
- Display Name
- Tipranavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tipranavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.22
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41329-0 | TipranavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Tipranavir: |
| es-MX | Spanish (Mexico) | Tipranavir: |
| et-EE | Estonian (Estonia) | Tipranaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Tipranavir: |
| fr-FR | French (France) | Tipranavir: |
| fr-BE | French (Belgium) | Tipranavir: |
| it-IT | Italian (Italy) | Tipranavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | tipranavir: |
| pt-BR | Portuguese (Brazil) | Tipranavir: Synonyms: TPV; |
| tr-TR | Turkish (Turkey) | Tipranavir: |
| zh-CN | Chinese (China) | 替拉那韦: Synonyms: 分离物; |